Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
Case Number: 1:2023cv00179
Filed: February 17, 2023
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on May 22, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
May 22, 2023 Opinion or Order Filing 26 ORDER granting (85) Motion to Consolidate Cases in case 1:22-cv-00856-CFC; granting (25) Motion to Consolidate Cases in case 1:23-cv-00179-CFC. These actions are consolidated for all purposes, and all papers shall be filed in Lead Case No. 22-856-CFC. Signed by Judge Colm F. Connolly on 5/22/2023. (nmf)
May 22, 2023 Case associated with lead case: Create association to 1:22-cv-00856-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 22-856-CFC ONLY. (nmf)
May 19, 2023 Filing 25 Joint MOTION to Consolidate Cases (Case No. 23-179-CFC into Lead Case No. 22-856-CFC) - filed by Novo Nordisk A/S. (Murray, Travis)
May 19, 2023 Filing 24 Letter to The Honorable Colm F. Connolly from Travis Murray regarding Motion to Consolidate and the Court's March 14, 2023 Order in C.A. 23-179. (Murray, Travis)
May 19, 2023 Opinion or Order Filing 23 SO ORDERED, re #22 STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to May 25, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 5/19/2023. (kmd)
May 18, 2023 Filing 22 STIPULATION TO EXTEND TIME to submit a proposed order for discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to May 25, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
May 4, 2023 Filing 21 NOTICE OF SERVICE of Defendant Orbicular Pharmaceutical Technology Pvt. Ltd.'s (1) Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Orbicular Pharmaceutical Technologies Pvt. Ltd..(Haynes, Christine)
May 4, 2023 Filing 20 NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
May 1, 2023 Filing 19 NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Claims - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
April 27, 2023 Opinion or Order Filing 18 SCHEDULING ORDER: Joinder of Parties due by 5/24/2024. Amended Pleadings due by 5/24/2024. Fact Discovery completed by 6/28/2024. Expert Discovery due by 10/22/2024. Joint Claim Construction Brief due by 11/8/2023. A Markman Hearing is set for 12/13/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 1/7/2025. A Final Pretrial Conference is set for 1/28/2025 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/3/2025 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 4/27/2023. (nmf)
April 24, 2023 Filing 17 Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding case coordination - re #11 Order,,, Set Deadlines,, SO ORDERED,, Set Deadlines,. (Attachments: #1 Proposed Scheduling Order)(Egan, Brian)
April 18, 2023 Opinion or Order SO ORDERED, re #16 STIPULATION TO EXTEND TIME to submit a proposed scheduling order to April 24, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Resetting Deadlines: Notice of Compliance deadline set for 4/24/2023.Ordered by Judge Colm F. Connolly on 4/18/2023. (kmd)
April 17, 2023 Filing 16 STIPULATION TO EXTEND TIME to submit a proposed scheduling order to April 24, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
April 14, 2023 Pro Hac Vice Attorneys William R. Zimmerman, William O. Adams, and Aryeh N. Feinstein for Orbicular Pharmaceutical Technologies Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
April 6, 2023 Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
April 6, 2023 Opinion or Order SO ORDERED, re #15 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 4/6/2023. (kmd)
April 5, 2023 Filing 14 NOTICE of Appearance by Christine Dealy Haynes on behalf of Orbicular Pharmaceutical Technologies Pvt. Ltd. (Haynes, Christine)
April 4, 2023 Filing 13 ANSWER to #9 Answer to Complaint, Counterclaim - by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis)
March 16, 2023 Opinion or Order SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney Nicholas A. Belair, Karen M. Cassidy Selvaggio, Joseph M. Reisman, Ph.D., William R. Zimmerman, Aryeh N. Feinstein and William O. Adams, filed by Orbicular Pharmaceutical Technologies Pvt. Ltd. Ordered by Judge Colm F. Connolly on 3/16/2023. (kmd)
March 15, 2023 Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Nicholas A. Belair, Karen M. Cassidy Selvaggio, Joseph M. Reisman, Ph.D., William R. Zimmerman, Aryeh N. Feinstein and William O. Adams - filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Farnan, Kelly)
March 14, 2023 Opinion or Order Filing 11 ORDER, having been assigned these cases which are listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before April 17, 2023, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed.ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 4/17/2023.) Signed by Judge Colm F. Connolly on 3/14/2023. Associated Cases: 1:23-cv-00101-CFC, 1:23-cv-00179-CFC(nmf)
March 14, 2023 Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orbicular Pharmaceutical Technologies Pvt. Ltd.. (Farnan, Kelly)
March 14, 2023 Filing 9 ANSWER to #1 Complaint, , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Orbicular Pharmaceutical Technologies Pvt. Ltd..(Farnan, Kelly)
February 24, 2023 Filing 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf)
February 22, 2023 Filing 7 AFFIDAVIT of Service for Summons, Complaint and related papers served on Orbicular Pharmaceutical Technologies Pvt. Ltd. c/o Joseph Reisman on February 21, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian)
February 22, 2023 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
February 17, 2023 Filing 6 Summons Issued as to Orbicular Pharmaceutical Technologies Pvt. Ltd. on 2/17/2023. (mpb)
February 17, 2023 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S, Corporate Parent Novo Nordisk US Holdings Inc., Corporate Parent Novo Nordisk Commercial Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (mpb)
February 17, 2023 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833 B2 ;9,265,893 B2. (mpb)
February 17, 2023 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/5/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 7/5/2025. (mpb)
February 17, 2023 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb)
February 17, 2023 Filing 1 COMPLAINT filed with Jury Demand against Orbicular Pharmaceutical Technologies Pvt. Ltd. ( Filing fee $ 402, receipt number ADEDC-4069694.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(mpb)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk Inc.
Represented By: Brian P. Egan
Represented By: Jack B. Blumenfeld
Represented By: Travis J Murray
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk A/S
Represented By: Brian P. Egan
Represented By: Jack B. Blumenfeld
Represented By: Travis J Murray
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Orbicular Pharmaceutical Technologies Pvt. Ltd.
Represented By: Christine Dealy Haynes
Represented By: Aryeh N. Feinstein
Represented By: William O. Adams
Represented By: William R. Zimmerman
Represented By: Kelly E. Farnan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?